L-Carnitine Research Information
Amino Acid Derivative
For Metabolic & Cellular Energy Research
⚠️ Important: This information is for educational and research purposes only. Always consult with a qualified healthcare professional before use.
📑 Contents
🔬 What is L-Carnitine?
L-Carnitine is a naturally occurring amino acid derivative that plays an essential role in energy metabolism by facilitating the transport of long-chain fatty acids into the mitochondrial matrix for β-oxidation. It is synthesized in the liver and kidneys from the essential amino acids lysine and methionine, and is also obtained through dietary sources, primarily red meat.
Beyond its metabolic functions, L-carnitine demonstrates antioxidant and anti-inflammatory effects, protecting tissues from oxidative damage induced by reactive oxygen species. This formulation is for injectable research use, available in pen and freeze-dried vial formulations.
⚡ How L-Carnitine Works
L-Carnitine works through multiple mechanisms to support metabolic health and cellular energy:
Fatty Acid Transport
Transports long-chain fatty acids into mitochondria for energy production
Antioxidant
Reduces oxidative stress and protects against reactive oxygen species
Anti-Inflammatory
Reduces inflammatory markers including CRP, IL-6, and TNF-α
L-Carnitine plays a critical role in mitochondrial function and fatty acid metabolism, contributing to ATP production. During ischemic conditions, myocardial L-carnitine levels fall rapidly; supplementation can replenish depleted stores.
📋 Research Applications
Cardiovascular Research
Studied for cardioprotective effects in coronary artery disease and heart failure
Metabolic Health
Investigating effects on lipid metabolism and mitochondrial function
Muscle & Sarcopenia
Improving muscle mass and function in sarcopenic patients
Liver Health
Ameliorating MASH and reducing inflammation in liver disease
📊 Clinical Studies
Dialysis & Carnitine Deficiency (Nutrients 2020)
- Eighty Japanese outpatients (62 hemodialysis patients and 18 peritoneal dialysis patients) received injectable L-carnitine 600 mg/day for 12 months
- Total carnitine, free carnitine, and acylcarnitine concentrations significantly increased after treatment
- Decreased muscle cramping after L-carnitine treatment was reported by 31% of patients who had undergone HD for >4 years
- Hemoglobin concentrations increased significantly at 12 and 24 months in the HD group
Cardiovascular Meta-Analysis (2026)
- Systematic review of 21 studies found L-carnitine supplementation reduced all-cause mortality by 27%, ventricular arrhythmias by 65%, and angina by 40%
- Significant reductions in inflammatory markers including CRP, IL-6, and TNF-α
- Decreased malondialdehyde (MDA) levels and increased antioxidant enzyme activity (SOD, GSH-Px)
- Reduced cardiac injury markers including CK-MB and troponin-I
Liver Transplantation & Sarcopenia (Clinical Nutrition ESPEN 2025)
- RCT of 53 HCV-related cirrhotic patients awaiting liver transplantation
- L-Carnitine supplementation significantly improved post-transplant muscle mass index (1 vs. 0 cm²/m²; P = 0.014)
- Mortality was significantly lower in the L-carnitine group (16.7% vs. 55.6%; P = 0.003)
- Survival rates comparable to non-sarcopenic patients
Pediatric Cardiac Surgery (European Journal of Pediatrics 2024)
- RCT of 60 children with congenital heart disease undergoing open-heart surgery
- L-Carnitine 50 mg/kg/day for 1 month pre-surgery significantly reduced post-operative oxidative stress (MDA), apoptosis markers, and myocardial injury markers (CK-MB, troponin I)
- Improved post-operative left ventricular ejection fraction
💉 Interactive Dosing Guide
Select your vial size and dose to see the corresponding volume, clicks, dosing frequency, and how many doses per vial:
🖊️ Step 1: Select Your Vial Size
💊 Step 2: Select Your Dose
Common research protocols: 50-300 mg per injection. Clinical studies used up to 600 mg/day injectable.
Vial Size
600mg Vial
Selected Dose
100 mg
Doses per Vial
6 doses
Pen Clicks
50 clicks
Volume
0.50 mL
Protocol Level
Level 2 (Standard)
Recommended Schedule
Daily - Standard Protocol
⚠️ Do not change your dose unless advised by a qualified professional.
📋 Protocol Level Summary
Based on research protocols: 25-300 mg per injection. Clinical studies used up to 600 mg/day injectable.
| Protocol Level | Target Dose | Frequency | Pen Clicks | Volume (mL) | Who It\'s For |
|---|---|---|---|---|---|
| Level 1 (Starting) | 25-50 mg | Daily | 12.5-25 clicks | 0.125-0.25 mL | New users, first 2 weeks |
| Level 2 (Standard) | 100 mg | Daily | 50 clicks | 0.50 mL | After 2 weeks, maintenance |
| Level 3 (Advanced) | 200 mg | Daily | 100 clicks | 1.00 mL | If more response needed |
| Level 4 (Maximum) | 300 mg | Daily | 150 clicks | 1.50 mL | Experienced users only |
⚠️ Do not change your dose unless advised by a qualified professional.
💉 Vial Users (Insulin Syringe)
Add 3mL of bacteriostatic water to your freeze-dried vial and mix gently. After reconstitution, use the table below to draw your dose:
Vial Size
600mg vial with 3mL bac water
| Dose | Frequency | Units on Syringe | Volume (mL) | Protocol Level |
|---|
⚠️ Always use a new sterile needle and syringe for each injection.
⚠️ Safety & Precautions
L-Carnitine is generally well-tolerated when dosed appropriately. In clinical studies, patients reported no side effects of intervention at 600 mg/day. The body excretes excess carnitine in urine.
- Mild gastrointestinal effects: Nausea or stomach upset at high doses
- Body odor: Fishy odor at very high doses (rare)
- Injection site reactions: Mild redness or tenderness at injection site
Important Safety Considerations:
- L-Carnitine is available as a dietary supplement and has a well-established safety profile
- Healthy individuals typically synthesize sufficient amounts without supplementation
- Do not use if allergic to L-Carnitine or any ingredients
- Do not use if pregnant or breastfeeding
⚠️ Warning: If you experience severe allergic reactions, difficulty breathing, or signs of anaphylaxis, seek immediate medical help.
📚 References
- Effects of l-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis. Nutrients. 2020;12(11):3371.
- Therapeutic potential of L-carnitine in coronary artery disease: a systematic review. Inflammopharmacology. 2026;34:1331-1342.
- Impact of L-carnitine supplementation on post-transplant outcomes in liver transplant candidates with sarcopenia. Clinical Nutrition ESPEN. 2025;70:50-58.
- L-carnitine decreases myocardial injury in children undergoing open-heart surgery. European Journal of Pediatrics. 2024;183(6):2783-2789.
This information is for educational and research purposes only. Always consult with a qualified healthcare professional.
Last updated: July 2026